Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease

Autor: Anna Ludovica Fracanzani, Antonio Grieco, Consuelo Cefalo, Maurizio Russello, Luca Miele, Luca Valenti, Alessandro Bellia, Giulio Marchesini, C. Masetti, Cristina Bertelli, Silvia Fargion
Přispěvatelé: AL Fracanzani, L Valenti, M Russello, L Miele, C Bertelli, A Bellia, C Masetti, A Grieco, G Marchesini Reggiani, S Fargion
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Male
Epidemiology
lcsh:Medicine
Nonalcoholic Steatohepatitis
Gallstones
Gastroenterology
Severity of Illness Index
TYPE 2 DIABETES
Liver disease
Endocrinology
Non-alcoholic Fatty Liver Disease
Risk Factors
Cholelithiasis
Nonalcoholic fatty liver disease
Prevalence
lcsh:Science
Abdominal obesity
Multidisciplinary
medicine.diagnostic_test
Liver Diseases
Fatty liver
Age Factors
Middle Aged
Liver
Liver biopsy
Obesity
Abdominal

Medicine
Female
medicine.symptom
Biliary Disorders
Research Article
Adult
medicine.medical_specialty
Clinical Research Design
Gastroenterology and Hepatology
Diabetes Complications
Insulin resistance
Sex Factors
NAFLD
Internal medicine
Diabetes mellitus
medicine
Animals
Humans
Obesity
Biology
GALLSTONE
Aged
Retrospective Studies
Nutrition
Diabetic Endocrinology
Population Biology
business.industry
Settore MED/09 - MEDICINA INTERNA
lcsh:R
Diabetes Mellitus Type 2
medicine.disease
Fatty Liver
Glucose
LIVER ENZYMES
Metabolic Disorders
lcsh:Q
Metabolic syndrome
Insulin Resistance
business
Zdroj: PLoS ONE, Vol 7, Iss 7, p e41183 (2012)
PLoS ONE
ISSN: 1932-6203
Popis: Background Nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) are both highly prevalent in the general population and associated with obesity and insulin resistance. We aimed to evaluate the prevalence of GD in a cross sectional study of NAFLD patients and to define whether the presence of GD is associated with diabetes and predicts more severe liver disease. Methodology/Principal Findings We merged databases of four Liver Units, comprising 524 consecutive biopsy-proven NAFLD (373 males) observed between January 2003 and June 2010. GD was diagnosed in 108 (20%), and 313 cases (60%) were classified by liver biopsy as nonalcoholic steatohepatitis (NASH). The GD subgroup was characterized by a significantly higher prevalence of females, prediabetes/diabetes, abdominal obesity and metabolic syndrome, older age, higher BMI, fasting glucose, HOMA-IR and lower ALT. The prevalence of GD progressively increased with advancing fibrosis and with the severity of necroinflammatory activity (p for trend = 0.0001 and = 0.01, respectively), without differences in the severity of steatosis. At multivariate analysis GD was associated with female gender (OR 1.37, 95% CI 1.04–1.8), age (OR 1.027, 95% CI1.003–1.05), fasting glucose (OR 1.21, 95% CI 1.10–1.33) and NASH (OR 1.40,95% CI 1.06–1.89), whereas ALT levels were associated with a lower GD risk (OR 0.98, 95% CI 0.97–0.99). When subjects with cirrhosis were excluded from analysis, the association between GD and fasting glucose, female gender, and NASH was maintained. Conclusion Patients with NAFLD have a high prevalence of GD, which characterizes subjects with altered glucose regulation and more advanced liver disease.
Databáze: OpenAIRE